Literature DB >> 16371535

Reperfusion of pulmonary arteriovenous malformations after embolotherapy.

Andrea Milic1, Raymond P Chan, Justine H Cohen, Marie E Faughnan.   

Abstract

PURPOSE: To describe the mechanisms and risk factors associated with reperfusion of successfully treated pulmonary arteriovenous malformations (PAVMs) after embolotherapy.
MATERIALS AND METHODS: Among 112 consecutive patients with PAVMs treated by embolotherapy, 19 patients were identified who had 33 angiographically confirmed reperfused PAVMs. A retrospective analysis of computed tomography (CT) and angiography was performed in patients with documented reperfused PAVMs in which reperfused PAVMs were compared with nonreperfused PAVMs. CT images were examined for persistence of the aneurysm and/or draining vein after initial embolotherapy and correlated with angiography to determine the mechanism of reperfusion. PAVM and embolic agent characteristics (eg, feeding artery size and number; PAVM location; coil size, number, and location) were evaluated for association with reperfusion. The outcomes of repeat embolotherapy for reperfused PAVMs were evaluated.
RESULTS: The PAVM aneurysm and/or draining vein persisted on CT after initial embolotherapy in all reperfused PAVMs and resolved in all nonreperfused PAVMs (in patients with nondiffuse PAVMs). Recanalization was the mechanism of reperfusion in 88%. Reperfusion was associated with the use of a single coil (P < .0001), oversized coils (P < .0001), coil placement more than 1 cm from the aneurysm (P < .0001), and increased feeding artery size (P < .001). Repeat embolotherapy for reperfused PAVMs was technically successful in 94% of cases. In the remaining 6% of cases, insufficient feeding artery length prevented safe repeat treatment. After a mean follow-up of 41 months, 42% of reperfused PAVMs in our series have been successfully treated again and occluded.
CONCLUSIONS: Recanalization is the most common mechanism of PAVM reperfusion. Increased feeding artery diameter, low number of coils, use of oversized coils, and proximal coil placement within the feeding artery are associated with reperfusion. Distal coil placement facilitates repeat embolization if reperfusion occurs.

Entities:  

Mesh:

Year:  2005        PMID: 16371535     DOI: 10.1097/01.RVI.0000182163.25493.BB

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  27 in total

1.  Embolization of pulmonary arteriovenous malformations using the Amplatzer vascular plug: successful treatment of 69 consecutive patients.

Authors:  Jonathan L Hart; Zaid Aldin; Philip Braude; Claire L Shovlin; James Jackson
Journal:  Eur Radiol       Date:  2010-06-24       Impact factor: 5.315

2.  Location of embolization affects patency after coil embolization for pulmonary arteriovenous malformations: importance of time-resolved magnetic resonance angiography for diagnosis of patency.

Authors:  Masashi Shimohira; Hiro Kiyosue; Keigo Osuga; Hideo Gobara; Hiroshi Kondo; Tetsuro Nakazawa; Yusuke Matsui; Kohei Hamamoto; Tomoya Ishiguro; Miyuki Maruno; Koji Sugimoto; Masamichi Koganemaru; Akira Kitagawa; Koichiro Yamakado
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

Review 3.  Management of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia patients.

Authors:  Kazim H Narsinh; Raja Ramaswamy; Thomas B Kinney
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

4.  Association between reperfusion and shrinkage percentage of the aneurysmal sac after embolization of pulmonary arteriovenous malformation: evaluation based on contrast-enhanced thin-section CT images.

Authors:  Satoko Makimoto; Takao Hiraki; Hideo Gobara; Hiroyasu Fujiwara; Toshihiro Iguchi; Yusuke Matsui; Hidefumi Mimura; Susumu Kanazawa
Journal:  Jpn J Radiol       Date:  2014-03-17       Impact factor: 2.374

5.  Persistence of pulmonary arteriovenous malformations after successful embolotherapy with Amplatzer vascular plug: long-term results.

Authors:  Ahmed Kamel Abdel Aal; Rafik Mohamed Ibrahim; Amr Soliman Moustafa; Maysoon Farouk Hamed; Souheil Saddekni
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

Review 6.  Pulmonary arteriovenous malformations: diagnosis.

Authors:  Sachin S Saboo; Murthy Chamarthy; Sanjeev Bhalla; Harold Park; Patrick Sutphin; Fernando Kay; John Battaile; Sanjeeva P Kalva
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 7.  Pulmonary arteriovenous malformations: endovascular therapy.

Authors:  Murthy R Chamarthy; Harold Park; Patrick Sutphin; Girish Kumar; Daniel Lamus; Sachin Saboo; Matthew Anderson; Sanjeeva P Kalva
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 8.  Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects.

Authors:  Nathaniel M Meier; Michael L Foster; John T Battaile
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 9.  Pulmonary arteriovenous malformations.

Authors:  Claire L Shovlin
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

Review 10.  Imaging of hereditary hemorrhagic telangiectasia.

Authors:  Marie-France Carette; Cosmina Nedelcu; Marc Tassart; Jean-Didier Grange; Marie Wislez; Antoine Khalil
Journal:  Cardiovasc Intervent Radiol       Date:  2008-10-30       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.